# Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization

> **NCT03118232** · PHASE4 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 13952 (actual)

## Conditions studied

- Hospitalization
- Infection

## Interventions

- **DRUG:** Chlorhexidine gluconate (CHG)
- **DRUG:** Iodophor (10% povidone-iodine)

## Key facts

- **NCT ID:** NCT03118232
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2023-10-10
- **Final completion:** 2023-10-10
- **Target enrollment:** 13952 (ACTUAL)
- **Last updated:** 2023-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118232, "Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03118232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*